|
|
|
|
Vol. 62, Issue 3, 521-528, September 2002
Department of Pharmacology, University of North Carolina School of
Medicine, Chapel Hill, North Carolina (C.A.-C., P.L.-Z., J.M., T.K.H.,
J.L.B.); and Inspire Pharmaceuticals, Inc., Durham, North Carolina
(J.L.B.)
To begin to address the functional interactions between constitutively
released nucleotides, ectonucleotidase activity, and P2Y
receptor-promoted signaling responses, we engineered the human P2Y1 receptor in a fusion protein with a member of the
ectonucleoside triphosphate diphosphohydrolase family, NTPDase1.
Membranes prepared from Chinese hamster ovary (CHO)-K1 cells
stably expressing either wild-type NTPDase1 or the P2Y1
receptor-NTPDase1 fusion protein exhibited nucleotide-hydrolytic
activities that were over 300-fold greater than activity measured in
membranes from empty vector-transfected cells. The molecular ratio for
nucleoside triphosphate versus diphosphate hydrolysis was approximately
1:0.4 for both the wild-type NTPDase1 and P2Y1-NTPDase1
fusion protein. Stable expression of the P2Y1-NTPDase1
fusion protein conferred an ADP and 2MeSADP-promoted Ca2+
response to CHO-K1 cells. Moreover, the maximal capacity of the nonhydrolyzable agonist ADP
S to stimulate inositol phosphate accumulation was similar, and the EC50 of ADP
S was lower
in the fusion protein than the wild-type receptor. In contrast, the
substantial nucleotide-hydrolyzing activity of the fusion protein
resulted in a greater than 50-fold shift to the right of the
concentration-effect curve of ADP for activation of phospholipase C
compared with the wild-type receptor. Heterologous expression of the
P2Y1 and other P2Y receptors results in marked increases in
basal inositol phosphate levels. Given the high nucleotidase activity
and apparently normal receptor signaling activity of the
P2Y1 receptor-NTPDase1 fusion protein, we quantitated basal
inositol phosphate accumulation in cells stably expressing either the
wild-type P2Y1 receptor or the fusion protein. Although
marked elevation of inositol phosphate levels occurred with wild-type
P2Y1 receptor expression, levels in cells expressing the
fusion protein were not different from those in wild-type CHO-K1 cells.
This article has been cited by other articles:
![]() |
C. Alvarado-Castillo, T. K. Harden, and J. L. Boyer Regulation of P2Y1 Receptor-Mediated Signaling by the Ectonucleoside Triphosphate Diphosphohydrolase Isozymes NTPDase1 and NTPDase2 Mol. Pharmacol., January 1, 2005; 67(1): 114 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Waldo, J. Corbitt, J. L. Boyer, G. Ravi, H. S. Kim, X.-d. Ji, J. Lacy, K. A. Jacobson, and T. K. Harden Quantitation of the P2Y1 Receptor with a High Affinity Radiolabeled Antagonist Mol. Pharmacol., November 1, 2002; 62(5): 1249 - 1257. [Abstract] [Full Text] [PDF] |
||||